-
A new “Jurassic Park” movie is coming out next year, the latest installment of the blockbuster series all about the dangerous hubris in trying to bring dinosaurs back from extinction. Paleogeneticist Beth Shapiro says the science may be flawed, but cloning extinct species is more realistic than you may think. In fact, that work is already underway — but with the slightly friendlier woolly mammoth.
-
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. After undergoing a new form of experimental therapy, Parkville resident Katie Pope Kopp is now in remission.
-
Donavon Decker became, in more ways than one, an ambassador of limb girdle muscular dystrophy type 2D, a rare degenerative disorder. But decades after he participated in patient trials and fundraised for research, drug companies are still nowhere close to a cure.